ARS Pharmaceuticals, Inc. (SPRY)
4.29
-0.27
(-5.92%)
USD |
NASDAQ |
Oct 09, 14:07
ARS Pharmaceuticals EPS Diluted (Quarterly) : -0.6277 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.6277 |
| March 31, 2026 | -0.6105 |
| December 31, 2025 | -0.4172 |
| September 30, 2025 | -0.5177 |
| June 30, 2025 | -0.4563 |
| March 31, 2025 | -0.3461 |
| December 31, 2024 | 0.5098 |
| September 30, 2024 | -0.1971 |
| June 30, 2024 | -0.1293 |
| March 31, 2024 | -0.1067 |
| December 31, 2023 | -0.0744 |
| September 30, 2023 | -0.1555 |
| June 30, 2023 | -0.183 |
| March 31, 2023 | -0.1588 |
| Date | Value |
|---|---|
| December 31, 2022 | 0.29 |
| September 30, 2022 | -0.214 |
| June 30, 2022 | -0.2098 |
| March 31, 2022 | -0.2387 |
| December 31, 2021 | -0.6694 |
| September 30, 2021 | -0.6473 |
| June 30, 2021 | -0.7024 |
| March 31, 2021 | -0.5426 |
| December 31, 2020 | -0.3771 |
| September 30, 2020 | -0.2454 |
| June 30, 2020 | -0.1859 |
| March 31, 2020 | -0.1596 |
| December 31, 2019 | -0.2108 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Capricor Therapeutics, Inc. | -0.7032 |
| Sionna Therapeutics, Inc. | -0.6619 |
| Nektar Therapeutics | -1.229 |
| Vertex Pharmaceuticals, Inc. | 4.310 |
| Ardelyx, Inc. | -0.0674 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -62.34M |
| Revenue (Quarterly) | 33.66M |
| Total Expenses (Quarterly) | 96.00M |
| Enterprise Value | 406.27M |
| Gross Profit Margin (Quarterly) | 61.83% |
| Profit Margin (Quarterly) | -185.2% |
| Earnings Yield | -50.66% |
| Normalized Earnings Yield | -50.67 |